Key Findings:  CBG and CBDV produced efficacy in models of Huntington's disease and epilepsy. CBC, Δ9‐THC, and THCV showed promise in models of seizure, hypomobility, Huntington's and Parkinson's disease
Type of Study:  Meta-analysis
Study Result:  Positive
Study Location(s):  United Kingdom
Year of Pub:  2020
Cannabinoids Studied:  Cannabichromene (CBC), Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Cannabis Flower derived